Qing Zhao, MD, PhD

Clinical Associate Professor, Boston University Chobanian & Avedisian School of Medicine

Publications

  • Published 5/13/2026

    Smith BE, Draper LM, Garmilla A, Perez CR, Singh N, Padilla LT, Xu EJK, Gaglione SA, Shen J, Conce Alberto WD, Zhao QH, Dobson CS, Roybal KT, Dougan M, Birnbaum ME, Dougan SK. Activation-dependent lentiviruses enable antigen-specific T cell expansion and transduction. bioRxiv. 2026 May 13. PMID: 42182167.

    Read at: PubMed

  • Published 2/27/2026

    Singhal R, Kim GH, Jacoba I, Zhao Q, Kim HT, Weber HC. Clinicopathological Characteristics and Survival Outcomes of Gastrointestinal Neuroendocrine Tumors in a Large Safety Net Hospital. J Clin Med. 2026 Feb 27; 15(5). PMID: 41827237.

    Read at: PubMed

  • Published 9/26/2025

    Lu Z, Zhou Y, Fan W, Choksi S, Sultan L, Katz MH, Wang DS, Zhao Q, Yang S. Biphasic (squamoid) papillary renal cell carcinoma: a distinct molecular and morphologic subtype within the PRCC spectrum. Virchows Arch. 2025 Sep 26. PMID: 41006900.

    Read at: PubMed

  • Published 8/23/2025

    Lu Z, Zhao Q, Xu H, Katz MH, Wang DS, Andry CD, Yang S. Molecular and Clinicopathological Profiling of Clear Cell Renal Cell Carcinoma with Rhabdoid Features: An Integrative Pathway-Based Stratification Approach. Cancers (Basel). 2025 Aug 23; 17(17). PMID: 40940841.

    Read at: PubMed

  • Published 9/22/2024

    Xu EJK, Smith BE, Conce Alberto WD, Walsh MJ, Lim B, Hoffman MT, Qiang L, Dong J, Garmilla A, Zhao QH, Perez CR, Gaglione SA, Dobson CS, Dougan M, Dougan SK, Birnbaum ME. Peptide-MHC-targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells. bioRxiv. 2024 Sep 22. PMID: 39345591.

    Read at: PubMed

Other Positions

  • Section Chief, Pathology & Laboratory Medicine
    Boston Medical Center
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Education

  • Jilin University, MD
  • McGill University, PhD
  • Jilin University, MSc